NDM-1 (New Delhi metallo-beta-lactamase) is an enzyme produced by certain strains of bacteria that have recently acquired the genetic ability to make this compound. Bacteria that produce NDM-1 are resistant to all commonly used beta-lactam antibiotics. Klebsiella, Escherichia and Acinetobacter are known to possess the gene for NDM-1, which can turn these bacteria into superbugs. Symptoms and signs of NDM-1 infection include fever, fatigue, and shock. Treatment depends upon the NDM-1 strain. Read more: NDM-1 Article
Related Disease Conditions
Urinary Tract Infections (UTIs)
A urinary tract infection (UTI) is an infection of the bladder, kidneys, ureters, or urethra. E. coli, a type of bacteria that...
Pneumonia is inflammation of the lungs caused by fungi, bacteria, or viruses. Symptoms and signs include cough, fever, shortness...
Although a fever technically is any body temperature above the normal of 98.6 F (37 C), in practice, a person is usually not...
Sepsis (blood poisoning) is a potentially deadly infection with signs and symptoms that include elevated heart rate, low or high...
Medical shock is a life-threatening medical condition. There are several types of medical shock, including: septic shock,...
E. coli (0157:H7) (Symptoms, Treatment, Prevention)
There are many types of E. coli (Escherichia coli ). E. coli can cause urinary tract and bladder infections, or lead to sepsis. E...
Antibiotic Resistance (Drug Resistance, Antimicrobial Resistance)
Drug resistance (antimicrobial resistance) is the ability of bacteria, fungi, parasites, and viruses to grow, even in the...
NDM-1 - Signs and Symptoms
What signs and symptoms did you experience with a diagnosed NDM-1-related infection?Post
NDM-1 - Treatment
What treatments or medications did you receive for an infection caused by NDM-1?Post View 2 Comments
NDM-1 - Prevention
In what ways do you prevent the risk of an infection with bacteria containing NDM-1?Post
Local ResourcesFind a local Doctor in your town
Treatment & Diagnosis
Medications & Supplements
Subscribe to MedicineNet's General Health Newsletter